麻豆社

The global pharmaceutical industry is facing some difficult strategic choices.

As the costs of research and development rise, other more reliable revenue streams look increasingly attractive.

In this edition of Global Business Peter Day hears from three leading industry insiders who share their visions for the future of the pharma business, discuss the focus on emerging healthcare models and tell him how the industry will find investment over the coming years